Tiamulin Market: Restraint
Use of Tiamulin results in some side effects, which is expected to be a major factor hindering growth of the Tiamulin market over the forecast period. Tiamulin injection can cause pain in the animals and long-term treatment with Tiamulin results in its resistance in bacteria.
Furthermore, stringent regulation by U.S. Food and Drug Administration for sale of Tiamulin drugs is also expected to adversely affect the tiamulin market growth. For instance, in 2013, U.S. Food and Drug Administration drafted new guidelines to ban the sale of any medically use antibiotics for non-medical applications. In 2014, Novartis Animal Health Inc. (now a part of Eli Lilly and Company) received warning form FDA, as it promoted its swine antibiotic product— Denagard (tiamulin hydrogen fumarate) for growth-promotion aspects.
Tiamulin Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients